These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18509191)

  • 1. Stopping trials for benefit can (sometimes) benefit patients.
    Pater JL; Goss P; Meyer R
    J Clin Oncol; 2008 Jun; 26(16):2787-8; author reply 2788. PubMed ID: 18509191
    [No Abstract]   [Full Text] [Related]  

  • 2. A probiotics trial on trial: the problem of timely detection of adverse advents in therapeutic trials.
    Giard RW
    J Clin Epidemiol; 2010 Apr; 63(4):347-9. PubMed ID: 19762211
    [No Abstract]   [Full Text] [Related]  

  • 3. Current controversies in data monitoring for clinical trials.
    Pocock SJ
    Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The many moral responsibilities of independent data-monitoring committees.
    Braillon A
    Am J Bioeth; 2011 Mar; 11(3):16-7. PubMed ID: 21400378
    [No Abstract]   [Full Text] [Related]  

  • 5. Research review boards dogged by criticism.
    Ledford H
    Nature; 2009 Apr; 458(7238):557. PubMed ID: 19340042
    [No Abstract]   [Full Text] [Related]  

  • 6. Stopping rules for clinical trials.
    Whitehead J
    Control Clin Trials; 2004 Feb; 25(1):69-70; author reply 71-2. PubMed ID: 14980750
    [No Abstract]   [Full Text] [Related]  

  • 7. Independence of the statistician who analyses unblinded data.
    Siegel JP; O'Neill RT; Temple R; Campbell G; Foulkes MA
    Stat Med; 2004 May; 23(10):1527-9. PubMed ID: 15122732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The statistician and the data monitoring committee.
    D'Agostino RB
    Stat Med; 2004 May; 23(10):1501-2. PubMed ID: 15122726
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trials in oncology stopped early for benefit.
    Wilcox RA; Djulbegovic B; Moffitt HL; Guyatt GH; Montori VM
    J Clin Oncol; 2008 Jan; 26(1):18-9. PubMed ID: 18165635
    [No Abstract]   [Full Text] [Related]  

  • 10. Should you join a clinical trial?
    Johns Hopkins Med Lett Health After 50; 2005 Mar; 17(1):6-7. PubMed ID: 15742482
    [No Abstract]   [Full Text] [Related]  

  • 11. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim monitoring of efficacy data is important and appropriate.
    Sydes MR; Parmar MK
    J Clin Epidemiol; 2008 Mar; 61(3):203-4. PubMed ID: 18226741
    [No Abstract]   [Full Text] [Related]  

  • 13. Committee for Medicinal Products for Human Use (CHMP) guideline on Data Monitoring Committees.
    ; ;
    Stat Med; 2006 May; 25(10):1639-45. PubMed ID: 16639775
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to clinical trial data. Data monitoring committees and selective outcome reporting.
    Ting JY
    BMJ; 2011 Feb; 342():d635. PubMed ID: 21285218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quality monitoring in multi-central large sample acupuncture clinical trials].
    Zhao L; Li Y; Zhang FW; Guang H
    Zhongguo Zhen Jiu; 2008 Nov; 28(11):835-7. PubMed ID: 19055291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stopping clinical trials early.
    Grant A
    BMJ; 2004 Sep; 329(7465):525-6. PubMed ID: 15345605
    [No Abstract]   [Full Text] [Related]  

  • 17. Data and safety monitoring boards: academic credit where credit is due?
    Armstrong PW; Califf RM
    JAMA; 2013 Oct; 310(15):1563-4. PubMed ID: 24129461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statement on Porzsolt in "monitor healthcare research"].
    Rettig-Stürmer G; Schieffer H; Müller E
    Urologe A; 2014 Mar; 53(3):390. PubMed ID: 23979444
    [No Abstract]   [Full Text] [Related]  

  • 19. An introductory note to the CHMP guidelines: choice of the non-inferiority margin and data monitoring committees by David Brown, Peter Volkers and Simon Day, Statistics in Medicine 2006; 25:1623-1627.
    Stat Med; 2007 Jan; 26(1):230-3; author reply 234-5. PubMed ID: 16900566
    [No Abstract]   [Full Text] [Related]  

  • 20. Who's minding the data? Data Monitoring Committees in clinical cancer trials.
    Keating P; Cambrosio A
    Sociol Health Illn; 2009 Apr; 31(3):325-42. PubMed ID: 19055588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.